Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anatomical and functional correlates of cystic macular edema in retinitis pigmentosa. | PLoS One | 2022 | 36269735 | PubTator, text mining | PubMed |
| Biallelic variants in coenzyme Q10 biosynthesis pathway genes cause a retinitis pigmentosa phenotype. | NPJ Genom Med | 2022 | 36266294 | PubTator, text mining | PubMed |
| Comprehensive analysis of the clinical significance, immune infiltration, and biological role of MARCH ligases in HCC. | Front Immunol | 2022 | 36263042 | PubTator, text mining | PubMed |
| Myosin motors in sensory hair bundle assembly. | Curr Opin Cell Biol | 2022 | 36257241 | PubTator, text mining | PubMed |
| TP53 mutation-associated immune infiltration and a novel risk score model in HNSCC. | Biochem Biophys Rep | 2022 | 36248764 | PubTator, text mining | PubMed |
| Prognostic Value of GIMAP4 and Its Role in Promoting Immune Cell Infiltration into Tumor Microenvironment of Lung Adenocarcinoma. | Biomed Res Int | 2022 | 36246963 | PubTator, text mining | PubMed |
| Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. | Front Genet | 2022 | 36246622 | PubTator, text mining | PubMed |
| Molecular pathology of Usher 1B patient-derived retinal organoids at single cell resolution. | Stem Cell Reports | 2022 | 36240775 | PubTator, text mining | PubMed |
| Highly Conserved Interaction Profiles between Clinically Relevant Mutants of the Cytomegalovirus CDK-like Kinase pUL97 and Human Cyclins: Functional Significance of Cyclin H. | Int J Mol Sci | 2022 | 36233116 | PubTator, text mining | PubMed |
| New CRISPR Tools to Correct Pathogenic Mutations in Usher Syndrome. | Int J Mol Sci | 2022 | 36232969 | PubTator, text mining | PubMed |
| Mutation and Interaction Analysis of the Glycoprotein D and L and Thymidine Kinase of Pseudorabies Virus. | Int J Mol Sci | 2022 | 36232898 | PubTator, text mining | PubMed |
| CRISPR/Cas9-A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects. | Int J Mol Sci | 2022 | 36232782 | PubTator, text mining | PubMed |
| Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis. | Int J Mol Sci | 2022 | 36232761 | PubTator, text mining | PubMed |
| Comprehensive analysis of somatic mutator-derived and immune infiltrates related lncRNA signatures of genome instability reveals potential prognostic biomarkers involved in non-small cell lung cancer. | Front Genet | 2022 | 36226174 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine development. | Front Oncol | 2022 | 36226063 | PubTator, text mining | PubMed |
| Mechanisms of Survival of Cytomegalovirus-Infected Tumor Cells. | Mol Biol | 2022 | 36217337 | PubTator, text mining | PubMed |
| Utility of No-Charge Panel Genetic Testing for Inherited Retinal Diseases in a Real-World Clinical Setting. | J Vitreoretin Dis | 2022 | 36213299 | PubTator, text mining | PubMed |
| Identifying a 6-Gene Prognostic Signature for Lung Adenocarcinoma Based on Copy Number Variation and Gene Expression Data. | Oxid Med Cell Longev | 2022 | 36211815 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment. | Front Public Health | 2022 | 36203656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=29